 |
94 Diseases |  |
58 Trials |
|
58 Trials |  |
2914 News |  |
| «12...27282930313233343536373839» |
- Mifeprex (mifepristone) / Danco Laboratories
Trial primary completion date, Metastases: Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer (clinicaltrials.gov) - Jun 25, 2015
P1, N=32, Active, not recruiting, Sponsor: University of Chicago
Trial primary completion date: Nov 2014 --> Nov 2016
- Mifeprex (mifepristone) / Danco Laboratories
Trial primary completion date: Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults (clinicaltrials.gov) - Jun 25, 2015
P1/2, N=75, Recruiting, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Trial primary completion date: Nov 2014 --> Nov 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment closed, Trial primary completion date: Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Jun 23, 2015
P1, N=22, Active, not recruiting, Sponsor: University of Chicago
Trial primary completion date: Jun 2015 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2015 --> Nov 2016
- Xtandi (enzalutamide capsule) / Pfizer, Astellas, Mifeprex (mifepristone) / Danco Laboratories
Trial primary completion date, Metastases: Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer (clinicaltrials.gov) - Jun 22, 2015
P1/2, N=108, Recruiting, Sponsor: University of Chicago
Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2015 --> Nov 2016 Trial primary completion date: Dec 2015 --> Dec 2016
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment open: Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers (clinicaltrials.gov) - Jun 20, 2015
P=N/A, N=10, Enrolling by invitation, Sponsor: New Mexico Cancer Care Alliance
Trial primary completion date: Dec 2015 --> Dec 2016 Active, not recruiting --> Enrolling by invitation
- Mifeprex (mifepristone) / Danco Laboratories
Trial primary completion date: Pretreatment With Mifepristone Prior to Mirena Insertion (clinicaltrials.gov) - Jun 11, 2015
P2, N=60, Active, not recruiting, Sponsor: Karolinska Institutet
Active, not recruiting --> Enrolling by invitation Trial primary completion date: Jan 2015 --> Dec 2015
- Nexplanon (etonogestrel implant) / Organon
Trial primary completion date: Quickstart of Nexplanon (clinicaltrials.gov) - Jun 11, 2015
P4, N=560, Recruiting, Sponsor: Karolinska Institutet
Trial primary completion date: Jan 2015 --> Dec 2015 Trial primary completion date: Feb 2015 --> Sep 2015
- Mifeprex (mifepristone) / Danco Laboratories
Trial primary completion date: The Effect of Mifepristone on Uterine Fibroids and Breast Tissue (clinicaltrials.gov) - Jun 11, 2015
P1, N=30, Completed, Sponsor: Karolinska Institutet
Trial primary completion date: Feb 2015 --> Sep 2015 Trial primary completion date: Jun 2008 --> Jun 2007
- Mifeprex (mifepristone) / Danco Laboratories
Trial primary completion date: A Randomized Clinical Trial of Mifepristone in PTSD (clinicaltrials.gov) - Apr 14, 2015
P2, N=136, Recruiting, Sponsor: James J. Peters Veterans Affairs Medical Center
Trial primary completion date: Jun 2008 --> Jun 2007 Trial primary completion date: Nov 2014 --> Nov 2015
- Mifeprex (mifepristone) / Danco Laboratories
New trial: Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine (clinicaltrials.gov) - Apr 14, 2015
P=N/A, N=170, Recruiting, Sponsor: Gynuity Health Projects
- | Mifeprex (mifepristone) / Danco Laboratories
New P4 trial: MMSAP: Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation (clinicaltrials.gov) - Apr 9, 2015
P4, N=100, Completed, Sponsor: Medstar Research Institute
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment open, Trial primary completion date: Trial of Mifepristone in Combat Veterans With Posttraumatic Stress Disorder (clinicaltrials.gov) - Apr 1, 2015
P2, N=80, Recruiting, Sponsor: James J. Peters Veterans Affairs Medical Center
Trial primary completion date: Nov 2014 --> Nov 2015 Active, not recruiting --> Recruiting | Trial primary completion date: Oct 2011 --> Oct 2015
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment closed, Trial primary completion date: Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers (clinicaltrials.gov) - Mar 5, 2015
P=N/A, N=10, Active, not recruiting, Sponsor: New Mexico Cancer Care Alliance
Active, not recruiting --> Recruiting | Trial primary completion date: Oct 2011 --> Oct 2015 Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Dec 2015
- Mifeprex (mifepristone) / Danco Laboratories
New P2 trial: STOMP-CSC: Short-Term Oral Mifepristone for Central Serous Chorioretinopathy (clinicaltrials.gov) - Feb 3, 2015
P2, N=30, Recruiting, Sponsor: Roger Goldberg, M.D., MBA
- Mifeprex (mifepristone) / Danco Laboratories
Trial initiation date, Trial primary completion date, Head-to-Head: Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation (clinicaltrials.gov) - Jan 22, 2015
P4, N=691, Not yet recruiting, Sponsor: Gynuity Health Projects
Enrolling by invitation --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Dec 2015 Initiation date: Dec 2014 --> Mar 2015 | Trial primary completion date: Dec 2015 --> Sep 2016
- | Mifeprex (mifepristone) / Danco Laboratories
New P4 trial: Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial (clinicaltrials.gov) - Jan 20, 2015
P4, N=416, Not yet recruiting, Sponsor: Gynuity Health Projects
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment open: Mifepristone and Misoprostol for Midtrimester Termination of Pregnancy in Uzbekistan (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=135, Recruiting, Sponsor: Gynuity Health Projects
Initiation date: Dec 2014 --> Mar 2015 | Trial primary completion date: Dec 2015 --> Sep 2016 Not yet recruiting --> Recruiting
- | Mifeprex (mifepristone) / Danco Laboratories
New P4 trial, Head-to-Head: Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation (clinicaltrials.gov) - Dec 11, 2014
P4, N=691, Not yet recruiting, Sponsor: Gynuity Health Projects
- Mifeprex (mifepristone) / Danco Laboratories
Trial primary completion date: Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in Kazakhstan (clinicaltrials.gov) - Nov 13, 2014
P=N/A, N=350, Recruiting, Sponsor: Gynuity Health Projects
Not yet recruiting --> Recruiting Trial primary completion date: Oct 2014 --> May 2015
- || Mifeprex (mifepristone) / Danco Laboratories
New P2/3 trial: Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis (clinicaltrials.gov) - Oct 22, 2014
P2/3, N=360, Completed, Sponsor: Mediterranea Medica S. L.
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment open, Phase classification: Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) (clinicaltrials.gov) - Oct 17, 2014
P2, N=24, Recruiting, Sponsor: Indiana University
Trial primary completion date: Oct 2014 --> May 2015 Active, not recruiting --> Recruiting | Phase classification: P3 --> P2
- | Mifeprex (mifepristone) / Danco Laboratories
Trial completion, Enrollment change: Mifemyo_2: Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids (clinicaltrials.gov) - Oct 17, 2014
P2/3, N=100, Completed, Sponsor: Mediterranea Medica S. L.
Active, not recruiting --> Recruiting | Phase classification: P3 --> P2 Recruiting --> Completed | N=200 --> 100
- Mifeprex (mifepristone) / Danco Laboratories
New P1/2 trial: Mifepristone for the Prevention of Relapses of Alcohol Drinking (clinicaltrials.gov) - Sep 19, 2014
P1/2, N=20, Recruiting, Sponsor: Brown University
- | Mifeprex (mifepristone) / Danco Laboratories
Enrollment open, HEOR: Comparative Effectiveness of Pregnancy Failure Management Regimens (clinicaltrials.gov) - Sep 11, 2014
P3, N=300, Recruiting, Sponsor: Courtney Schreiber
Recruiting --> Completed | N=200 --> 100 Not yet recruiting --> Recruiting
- Mifeprex (mifepristone) / Danco Laboratories
Trial completion, Trial primary completion date: Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion (clinicaltrials.gov) - Aug 15, 2014
P=N/A, N=401, Completed, Sponsor: Gynuity Health Projects
Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Apr 2014 --> Jul 2014
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment open, BRCA Biomarker, IO biomarker: BRCA1/2 and Effect of Mifepristone on the Breast (clinicaltrials.gov) - Aug 12, 2014
P2, N=45, Recruiting, Sponsor: Karolinska Institutet
Recruiting --> Completed | Trial primary completion date: Apr 2014 --> Jul 2014 Not yet recruiting --> Recruiting
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment closed: Pretreatment With Mifepristone Prior to Mirena Insertion (clinicaltrials.gov) - Aug 12, 2014
P2, N=60, Active, not recruiting, Sponsor: Karolinska Institutet
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Mifeprex (mifepristone) / Danco Laboratories
Trial completion: Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia (clinicaltrials.gov) - Jul 10, 2014
P=N/A, N=120, Completed, Sponsor: Gynuity Health Projects
Recruiting --> Active, not recruiting Recruiting --> Completed
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment change: Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (clinicaltrials.gov) - Jun 19, 2014
P2, N=24, Completed, Sponsor: Gynecologic Oncology Group
Recruiting --> Completed N=52 --> 24
- | Mifeprex (mifepristone) / Danco Laboratories
Enrollment closed: Investigation of Mifepristone (RU486) on Stress Sensitivity and Relapse Prevention in Cocaine Dependent Patients (clinicaltrials.gov) - Jun 5, 2014
P2/3, N=80, Active, not recruiting, Sponsor: New York State Psychiatric Institute
N=52 --> 24 Recruiting --> Active, not recruiting
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment open: Medication Enhanced Rapid Therapy (clinicaltrials.gov) - May 13, 2014
P1, N=90, Recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Active, not recruiting Active, not recruiting --> Recruiting
- Mifeprex (mifepristone) / Danco Laboratories
Trial primary completion date: Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks) (clinicaltrials.gov) - May 11, 2014
P4, N=504, Completed, Sponsor: Gynuity Health Projects
Active, not recruiting --> Recruiting Trial primary completion date: Jun 2014 --> May 2014
- Mifeprex (mifepristone) / Danco Laboratories
Trial completion date: Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks) (clinicaltrials.gov) - May 11, 2014
P4, N=504, Completed, Sponsor: Gynuity Health Projects
Trial primary completion date: Jun 2014 --> May 2014 Trial completion date: Sep 2014 --> May 2014
- Mifeprex (mifepristone) / Danco Laboratories
Trial completion: Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks) (clinicaltrials.gov) - May 11, 2014
P4, N=504, Completed, Sponsor: Gynuity Health Projects
Trial completion date: Sep 2014 --> May 2014 Recruiting --> Completed
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment closed: Medication Enhanced Rapid Therapy (clinicaltrials.gov) - Apr 30, 2014
P1, N=90, Active, not recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Completed Recruiting --> Active, not recruiting
- Mifeprex (mifepristone) / Danco Laboratories
Trial completion: Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks (clinicaltrials.gov) - Apr 3, 2014
P=N/A, N=50, Completed, Sponsor: Stanford University
Recruiting --> Active, not recruiting Recruiting --> Completed
- Mifeprex (mifepristone) / Danco Laboratories
New P1 trial: Medication Enhanced Rapid Therapy (clinicaltrials.gov) - Mar 27, 2014
P1, N=90, Recruiting, Sponsor: Washington University School of Medicine
- Mifeprex (mifepristone) / Danco Laboratories
Trial completion: Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders (clinicaltrials.gov) - Mar 18, 2014
P1/2, N=16, Completed, Sponsor: Eric Lenze
Recruiting --> Completed Active, not recruiting --> Completed
- Mifeprex (mifepristone) / Danco Laboratories
Trial completion: SaMi2: Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks (clinicaltrials.gov) - Mar 17, 2014
P3, N=50, Completed, Sponsor: Boston University
Active, not recruiting --> Completed Recruiting --> Completed
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment closed: Cervical Preparation Before Dilation and Evacuation (clinicaltrials.gov) - Mar 13, 2014
P=N/A, N=300, Active, not recruiting, Sponsor: Planned Parenthood League of Massachusetts
Recruiting --> Completed Recruiting --> Active, not recruiting
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment change: Treatment of Schizoaffective Disorder Using Mifepristone (clinicaltrials.gov) - Mar 11, 2014
P2/3, N=14, Terminated, Sponsor: Stanford University
Recruiting --> Active, not recruiting N=30 --> 14
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment closed, Metastases: Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer (clinicaltrials.gov) - Mar 2, 2014
P1, N=32, Active, not recruiting, Sponsor: University of Chicago
N=30 --> 14 Recruiting --> Active, not recruiting
- | Mifeprex (mifepristone) / Danco Laboratories
Trial completion: De-Medicalizing Mifepristone Medical Abortion (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=4410, Completed, Sponsor: Gynuity Health Projects
Recruiting --> Active, not recruiting Recruiting --> Completed
- | Mifeprex (mifepristone) / Danco Laboratories
Trial completion: Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People (clinicaltrials.gov) - Feb 22, 2014
P1/2, N=48, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting --> Completed Active, not recruiting --> Completed
- Mifeprex (mifepristone) / Danco Laboratories
Enrollment change: Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial (clinicaltrials.gov) - Feb 17, 2014
P=N/A, N=120, Completed, Sponsor: Gynuity Health Projects
Active, not recruiting --> Completed N=260 --> 120
- Mifeprex (mifepristone) / Danco Laboratories
Trial completion: Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP)) (clinicaltrials.gov) - Feb 17, 2014
P=N/A, N=238, Completed, Sponsor: Gynuity Health Projects
N=260 --> 120 Recruiting --> Completed
- Mifeprex (mifepristone) / Danco Laboratories
Biomarker, Trial termination: Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer (clinicaltrials.gov) - Jan 28, 2014
P0, N=4, Terminated, Sponsor: University of California, San Diego
Recruiting --> Completed Recruiting --> Terminated; Inadequate subject accrual
- Mifeprex (mifepristone) / Danco Laboratories
Biomarker, Enrollment change: Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer (clinicaltrials.gov) - Jan 28, 2014
P0, N=4, Terminated, Sponsor: University of California, San Diego
Recruiting --> Terminated; Inadequate subject accrual N=66 --> 4
- Mifeprex (mifepristone) / Danco Laboratories
New P1 trial: Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (clinicaltrials.gov) - Jan 23, 2014
P1, N=22, Recruiting, Sponsor: University of Chicago
- Mifeprex (mifepristone) / Danco Laboratories
Trial withdrawal: RU-486 in the Treatment of Bipolar Depression (clinicaltrials.gov) - Jan 20, 2014
P2, N=0, Withdrawn, Sponsor: University of British Columbia
N=66 --> 4 Suspended --> Withdrawn